Nicotine withdrawal and Κ-opioid receptors

Psychopharmacology

Volumn 210, Issue 2, 2010, Pages 221-229

  McCarthy, Michael J ^a   Zhang, Hailing ^a   Neff, Norton H ^b   Hadjiconstantinou, Maria ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

opioid receptors; Adenylyl cyclase; Binding; Caudate putamen; Desensitization; MRNA, ; Nicotine withdrawal; Nucleus accumbens; S binding;

Indexed keywords

ADENYLATE CYCLASE; DYNORPHIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; MESSENGER RNA; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NICOTINE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; AVERSIVE BEHAVIOR; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; LONG TERM EXPOSURE; MALE; MESENCEPHALON; MOUSE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUTAMEN; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; DESENSITIZATION; PREFRONTAL CORTEX; PROTEIN BINDING; SMOKING CESSATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ADENYLATE CYCLASE; ANIMALS; BASAL GANGLIA; BENZENEACETAMIDES; CAUDATE NUCLEUS; DYNORPHINS; GTP-BINDING PROTEINS; MALE; MICE; NICOTINE; NUCLEUS ACCUMBENS; PUTAMEN; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77953290901     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1674-5     Document Type: Article

References (65)

1. Appleyard SM, Patterson TA, Jin WZ, Chavkin C (1997) Agonist-induced phosphorylation of the kappa-opioid receptor. J Neurochem 69:2405-2412
2. Appleyard SM, Celver J, Pineda V, Kovoor A, Wayman GA, Chavkin C (1999) Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin. J Biol Chem 274:23802-23807 (Pubitemid 29390303)
3. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M, Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isoenzymespecific. J Biol Chem 272:5040-5047 (Pubitemid 27090057)
4. Bals-Kubik R, Ableiter A, Herz A, Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped, by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489-495
5. Berrendero F, Kieffer BL, Maldonado R (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice. J Neurosci 22:10935-10940
6. Berrendero F, Mendizabal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, Maldonado R (2005) Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalta gene. J Neurosci 25:1103-1112
7. Carlezon WA Jr, Beguin C, DiNieri JA, Baurnan MH, Richards MR, Todtenkopf MS, Rotham RB, Maz Z, Lee D-Y-W, Cohen BM (2006) Depressive like effects of the K-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447
8. Chem Y (2000) Regulation of adenyly cyclase in the central nervous system. Cell Signal. 12:195-204
9. Dhatt R, Gudehithlu KP, Wemlinger TA, Tejwani GA, Neff NH, Hadjiconstantinou. M (1995) Preproenkephalta mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. J Neurochem 64:1878-1883
10. Damaj MI, Kao W, Martin BR (2003) Characterization of spontaneous and precipitated nicotine withdrawal in mouse. J Pharmacol Exp Ther 307:526-534
11. Di Chiara G, Imperato A. (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
12. Epping-Jordan MP, Watktas SS, Koob GF, Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76-79
13. Foulds J, Stapelton JA, bell N, Swettenham J, Jarvis MJ, Russell MAH (1997) Mood and physiological effects of subcutaneous nicotine in smokers and never smokers. Drug Alcohol Depend 44:105-115
14. Galeote L, Maldonado R, Berrendero F (2008) Involvement of kappa/ dynoiphin system in the development of tolerance to nicotineinduced antinociception. J Neurocheni 105:1358-1368
15. Galeote L, Berrendero F, Bura SA, Zimmer A, Maldonado R (2009) Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice. Int J Neuropsychopharmacol 12:615-625
16. Gomnians J, Stolerman IP, Shoaib M (2000) Antagonism of the discriminative and aversive stimulus properties of nicotine in C57B1/6J mice. Neuropharmacology 39:2840-2847
17. 35S] GTP gamma S autoradiography: optimization for high sensitivity. Eur J Pharmacol 422:1-13
18. 35S]GTPyS binding assay: approaches and applications in pharmacology. Life Sci 74:489-508
19. Fleishman SJ, I-Iennigfield JF (2000) Tolerance to repeated nicotine administration on performance, subjective, and physiological response to nonsmokers. Psychopharmacology 152:321-333
20. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW (1991) Symptoms of tobacco withdrawal. A replication and extension. Arch General Psych 48:52-59
21. Ise Y, Narita M, Nagase H, Suzuki T (2000) Modulation of opioidergic system on mecamylamine-precipitated nicotinewithdrawal aversion in rats. Psychopharmacology 151:49-54
22. Isola R, Vogelsberg V, Wemltager TA, Neff NH, Hadjiconstantinou M (1999) Nicotine abstinence in the mouse. Brain Res 850:189-196
23. Isola R, Duchemin A-M, Tejwani GA, Neff NH, Hadjiconstantinou M (2000) Glutamate receptors participate in the nicotine-induced changes of met-enkephalin in striatum. Brain Res 878:72-78
24. Isola R, Zhang H, Duchemin A-M, Tejwani GA, Neff NH, Hadjiconstantinou M (2002) Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinense mouse. Neurosci Lett 325:67-71
25. Isola R, Zhang H, Tejwani GA, Neff NH, Hadjiconstantinou M (2008) Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal. Synapse 62:448-455
26. Isola R, Zhang H, Tejwani GA, Neff NH, Hadjiconstantinou M (2009) Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum. Psychopharmacology 201:507-516
27. Izenwasser S, Buzas B, Cox BM (1993) Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudateputamen and nucleus accumbens. J Pharmacol Exp Ther 267:145-152
28. Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav 70:531-549
29. Kim K-S, Lee K-W, Im J-Y, Yoo JY, Kim S-W, Lee J-K, Nestler EJ, Han P-L (2006) Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action. PNAS 103:3908-3913
30. Kitchen I, Slowe SJ, Matthes HWD, Kieffer B (1997) Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu opioid receptor gene. Brain Res 778:73-88
31. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The dysphoric component of stress is encoded by activation of the dynorphin K-opioid system. J Neurosci 28:407-414
32. Liu-Chen L-Y (2004) Agonist-induced regulation and trafficking of K opioid receptors. Life Sci 75:511-536
33. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, Carlezon WA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330
34. Malta. DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, Wilson OB (1992) Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779-784
35. Malta DH, Lake RJ, Carter VA, Cunningham JS, Wilson OB (1993) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology 112:339-342
36. McLaughlin JP, Marton-Popovici M, Chavkin C (2003a) K-Opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23:5674-5683 (Pubitemid 36807845)
37. McLaughlin JP, Xu M, Mackie K, Chavkin C (2003b) Phosphorylation of a carboxyl-termtaal serine within the kappa opioid receptor produces desensitization and internalization. J Biol Chem 278:34631-34640 (Pubitemid 37553312)
38. McLaughlin JP, Myers LC, Zarek PE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Chavkin C (2004) Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem. 279:1810-1818
39. Meshul CK, McGinty JF (2000) Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated, with synaptic vesicles in axons. Neuroscience 96:91-99
40. Newton SS, Thome J, Wallace TL, Shirayama Y, Schlostager L, Sakai N, Chen J, Neve R, Nestler EJ (2002) Inhibition of cAMP response element-binding or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22:10883-10890
41. Paxinos G, Franklin BL (2001) The mouse brain in stereotaxic coordinates. Academic, San Diego
42. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated, by kappa opiate receptors. Science 233:774-776 (Pubitemid 16016229)
43. Risinger FO, Oakes RA (1995) Nicotine-induced conditioned place preference and conditioned taste aversion in mice. Pharmacol Biochem Behav 51:457-461
44. Schwarzer C (2009) 30 years of dynorphin-new insights on their functions in neuropsychiatrie diseases. Pharmacol Ther 123 (3):353-370
45. Shippenberg TS, Chefer VI, Zapata A, Heidbreder CA (2001) Modulation of the behavioral and neurochemical effects of psychostimulants by K-opioid receptor systems. Ann NY Acad Sci 937:50-73
46. Shippenberg TS, Zapata A, Chefer VI (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacology & Therapeutics 116:306-321
47. Shirayama Y, Ishida H, Iwata M, Hazama G, Kawahara R, Duman RS (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism, produces antidepressant-like effects. J Neurochem 90:1258-1268
48. Sim LJ, Selley DE, Childers SR (1995) In vitro autoradiography of receptor-mediated G-proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]triphosphate binding. Proc Nat Acad. Sci 92:7242-7246
49. Simonin F, Valverde O, Smadja C, Slowe S, Kitchen I, Dierich A, Le Meur M, Roques BP, Maldonado R, Kieffer BL (1998) Disruption of the K-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological action of the selective K-agonist U-50,488H and attenuates morphine withdrawal. The EMBO Journal 17:886-897 (Pubitemid 28077643)
50. Skjei KL, Markou A (2003) Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats. Psychopharmacology 168:280-292
51. Spanagel R (1995) Modulation of drug-induced sensitization processes by endogenous opioid systems. Behavioural Brain Res 70:37-49
52. Svingos A, Colago EEO (2002) K-Opioid and NMDA glutamate receptors are differentially targeted within the rat medial prefrontal cortex. Brain Res 946:262-271
53. Svingos A, Colago EEO, Pickel V (1999) Cellular sites for dynorphin activation of Κ-opioid receptors in the rat nucleus accumbens shell. J Neurosci 19:1804-1813
54. Svingos A, Chavkin C, Colago EE, Pickel VM (2001) Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse 42:185-192
55. Taussig R, Tang WJ, Hepler JR, Gilman AG (1994) Distinct, patterns of bidirectional regulation of mammalian adenyly cyclases. J Biol Chem 269:6093-6100
56. Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr (2004) Effects of kappa-opioid receptor ligands on intracranial selfstimulation in rats. Psychopharmacology 172:463-470
57. Tomasiewicz HC, Todtenkopf MS, Chartoff EH, Cohen BM, Carlezon WA Jr (2008) The kappa-opioid agonist U69, 593 blocks cocaine-induced enhancement of brain stimulation reward. Biol Pscychiatry 64:982-988
58. Visel A, Alvarez-Bolado G, Thaller C, Eichelle G (2006) Comprehensive analysis of the expression patterns of the adenylate cyclase gene family in the developing and adult mouse brain. J Comp Neurol 496:684-697
59. Waldhoer M, Barlett SE, Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953-990
60. Wang Y, Van Bockstaele EJ, Liu-Chen L-Y (2008) In vivo trafficking of endogenous opioid receptors. Life Sci 83:693-699
61. Watkins SS, Stinus L, Koob GF, Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292:1053-1064
62. Xia Y-F, he L, Whistler JL, Hjeilmstad GO (2008) Acute methamphetamine exposure selectively desensitizes Κ-opioid receptors in the nucleus accumbens. Neuropsychopharmacology 33:892-900
63. Xu H, Wang X, Partilla JS, Bishop-Mathis K, Benaderet TS, Dersch CM, Simpson DS, Prisinzano TE, Rothman RB (2008) Differential effects of opioid, agonists on G proteta expression in CHO cells expressing cloned human opioid receptors. Brain Res Bulletin 77:49-54
64. Xuc Y, Domino EF (2008) Tobacco/nicotine and endogenous brain opioids. Prog Neuropsychopharmacol Biol Psychiatry 32 (5): 1131-1138
65. Zimmer A, Valjent E, Konig M, Zimmer AM, Robledo P, Hahn H, Valverdre O, Maldonado R (2001) Absence of Δ-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. J Neurochem 21:9499-9505 (Pubitemid 33096894)